Market Overview

A Peek Into The Market Before The Trading Starts

A Peek Into The Market Before The Trading Starts
Related ADBE
5 Tailwinds That Could Carry Yext Shares Higher
The Week Ahead: Earnings, Earnings, And More Earnings
Windward Capital Management Co Buys DowDuPont Inc, Boeing Co, Lockheed Martin Corp, Sells L ... (GuruFocus)
Related RDY
20 Stocks Moving In Thursday's Pre-Market Session
12 Biggest Mid-Day Gainers For Thursday

Pre-open movers US stock futures are higher this morning. Futures for the Dow Jones Industrial Average surged 54 points to 14,744.00 and S&P 500 index futures rose 6.40 points to 1,587.80. Nasdaq 100 futures gained 15.25 points to 2,873.50.

A Peek Into Global Markets European markets were higher today. The STOXX Europe 600 Index surged 1.50%, London's FTSE 100 index gained 1.01%, French CAC 40 Index climbed 1.82% and German DAX 30 index rose 1.47%.

Asian markets ended mixed, with Japan's Nikkei Stock Average falling 1.04%, China's Shanghai Composite dropping 0.41% and Australia's ASX/S&P500 rising 1.60%. Hong Kong's Hang Seng Index gained 2.43% and India's Sensex dropped 0.41%.

Broker Recommendation Analysts at Jefferies upgraded Adobe Systems (NASDAQ: ADBE) from “hold” to “buy.” The target price for Adobe has been raised from $45 to $57.

Adobe's shares closed at $44.37 yesterday.

Breaking news

  • Dr. Reddy's Laboratories (NYSE: RDY) announced today that is has launched Lamotrigine Extended-Release Tablets (25 mg, 50 mg, 100 mg, 200 mg, 300 mg) a therapeutic equivalent generic version of Lamictal® XR (lamotrigine) in the US market on June 25, 2013, following the approval by the United States Food & Drug Administration (USFDA) of Dr. Reddy's ANDA for Lamotrigine XR tablets. To read the full news, click here.
  • Pluristem Therapeutics (NASDAQ: PSTI) today announced that its wholly owned subsidiary, Pluristem Ltd., has entered into an exclusive out-license and strategic partnership agreement with Cha Bio&Diostech (Kosdaq:CHA) for the use of Pluristem's PLacental eXpanded (PLX) cells for peripheral artery disease (PAD), specifically in two indications: the treatment of Critical Limb Ischemia (CLI), and Intermediate Claudication (IC) in South Korea. To read the full news, click here.
  • Walmart (NYSE: WMT) and SolarCity (NASDAQ: SCTY) announced Tuesday the completion of projects at eight Walmart stores and two Sam's Clubs across the state of Maryland that will generate clean, renewable electricity. To read the full news, click here.
  • Pacific Premier Bancorp (NASDAQ: PPBI) announced that it has completed the acquisition of San Diego Trust Bank, a San Diego based state-chartered bank. To read the full news, click here.

Posted-In: Jefferies US Stock FuturesNews Futures Global Pre-Market Outlook Markets


Related Articles (ADBE + PPBI)

View Comments and Join the Discussion!

Partner Center